Form4insider filings, from the source

SEC Form 4 · accession 0000914190-15-000480

Arno Therapeutics, Inc · ARNI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 4, 2015
Accepted (ET)
Nov 6, 2015 · 2:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001195116

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———1,596,272IBy Commercial Street Capital, LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F6$0.36Nov 4, 2015A48,399A—Nov 4, 2025Common Stock48,39948,399D
Stock Option (right to buy)F2$8.00holding————Nov 5, 2020Common Stock3,7503,750D
Stock Option (right to buy)F3$2.40holding————Nov 4, 2023Common Stock205,344205,344D
Stock Option (right to buy)F4$2.90holding————Jan 24, 2024Common Stock34,22434,224D
Stock Option (right to buy)F5$0.85holding————Nov 4, 2024Common Stock136,784136,784D
2012 Series A Warrants (right to buy)F1$2.40holding———Oct 29, 2013Nov 26, 2017Common Stock868,055868,055I
2013 Series D Warrants (right to buy)F1$4.00holding———Oct 29, 2013Oct 29, 2018Common Stock687,500687,500I

Explanation of responses